Study Stopped
Study was never officially approved by IRB and never open to enrollment. Submission withdrawn due to lack of funding.
Understanding Visual Processing After Occipital Stroke
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to investigate how visual orientation discrimination and metacognition (i.e., perceptual confidence) are affected by occipital stroke that causes hemianopia and quadrantanopia in adults. This research will provide insight as to how the residual visual system, which not directly damaged by the occipital stroke, processes orientation (assayed in terms of orientation discrimination) and metacognition (by measuring perceptual confidence for orientation discrimination). These measures will be used to refine computational models that attempt to explain how the brain copes with loss of primary visual cortex (V1) as a result of stroke. This knowledge is essential to devise more effective visual rehabilitation therapies for patients suffering from occipital strokes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2029
October 8, 2024
October 1, 2024
2.8 years
April 1, 2024
October 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Orientation discrimination threshold
Assessment of Static Orientation Discrimination. For each subject, the investigators will measure the ability to correctly identify the orientation of non-moving visual stimuli that vary in degree of angle tilt to the right or left of vertical. The investigators will measure the degree of angle tilt that can be reliably detected at a 72-75% correct level of performance. Tilt difference from vertical will vary between 80° (maximum) and 0.1° (minimum) based on subject performance and an adaptive staircase that will change tilt magnitude depending on subject performance, increasing the tilt (making the task easier) for each incorrect answers and decreasing tilt (making the task harder) after a number of correct answers in a row.
Baseline
Perceptual Confidence in Orientation Discrimination
Assessment of Metacognition (i.e., perceptual confidence) in Orientation Discrimination. For each subject, the investigators will measure their confidence in identifying an object's tilt to the right or left of vertical. A running tally of 'response points' will be collected during the orientation testing. Points will be awarded for each response on a scale, with the highest points awarded for "correct discrimination \& high confidence", intermediate points awarded for "correct discrimination \& low confidence", followed by "incorrect discrimination \& low confidence" and with points subtracted for "incorrect discrimination \& high confidence". Total points will be recorded for each test, with the patient asked to accumulate the highest number of points they can during the task.
Baseline
Eligibility Criteria
Subjects will all be individuals who have sustained partial vision loss after an occipital lobe stroke.
You may qualify if:
- Residents of the United States or Canada
- MRI and/or CT scans showing unilateral stroke or stroke-like damage to primary visual cortex or its immediate afferent white matter sustained 1-year or more prior to enrollment
- Reliable visual field defects in both eyes as measured by Humphrey, Macular Integrity Assessment (MAIA), Goldmann, and/or equivalent perimetry. This deficit must be large enough to enclose a 5-deg diameter visual stimulus.
- Ability to fixate on visual targets reliably for 1000ms (as demonstrated by visual fields, and verified in study participation)
- Willing, able, and competent to provide informed consent
- Cognitively able to understand and respond to written and oral instructions in English
You may not qualify if:
- Past or present ocular disease interfering with visual acuity
- Corrected vision worse than 20/40 in either eye
- Presence of damage to the dorsal Lateral Geniculate Nucleus
- Diffuse, whole brain degenerative processes
- Brain damage deemed by study staff to potentially interfere with testing ability or outcome measures
- Documented history of traumatic brain injury
- Documented history of drug/alcohol abuse
- Current use neuroactive
- Cognitive or seizure disorders
- Subjects with one-sided attentional neglect
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- James V. Aquavella Professor of Ophthalmology, Associate Chair for Research, Dept. Ophthalmology
Study Record Dates
First Submitted
April 1, 2024
First Posted
April 8, 2024
Study Start
December 1, 2025
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2029
Last Updated
October 8, 2024
Record last verified: 2024-10